Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)
Bangladesh
· Delayed Price · Currency is BDT
128.60
+1.20 (0.94%)
At close: Jan 29, 2025
Beacon Pharmaceuticals Revenue
Beacon Pharmaceuticals had revenue of 2.80B BDT in the quarter ending September 30, 2024, with 20.82% growth. This brings the company's revenue in the last twelve months to 11.18B, up 26.92% year-over-year. In the fiscal year ending June 30, 2024, Beacon Pharmaceuticals had annual revenue of 10.70B with 25.76% growth.
Revenue (ttm)
11.18B
Revenue Growth
+26.92%
P/S Ratio
2.66
Revenue / Employee
2.69M
Employees
4,162
Market Cap
29.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 10.70B | 2.19B | 25.76% |
Jun 30, 2023 | 8.51B | 487.21M | 6.07% |
Jun 30, 2022 | 8.02B | 901.58M | 12.66% |
Jun 30, 2021 | 7.12B | 1.53B | 27.37% |
Jun 30, 2020 | 5.59B | 943.92M | 20.31% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grameenphone | 161.36B |
Square Pharmaceuticals PLC. | 70.04B |
British American Tobacco Bangladesh Company | 93.12B |
Walton Hi-Tech Industries | 75.24B |
Robi Axiata PLC. | 101.06B |
Bangladesh Export Import Company | 25.18B |
BRAC Bank PLC. | 54.86B |
Berger Paints Bangladesh | 27.70B |